Pacer Advisors, Inc. Halozyme Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

$40.5 Billion
Q4 2024

A detailed history of Pacer Advisors, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 29,006 shares of HALO stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,006

Previous 29,261 0.87%

Holding current value

$1.66 Million

Previous $1.67 Million 17.2%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$42.57 - $61.09 $10,855 - $15,577	-255 Reduced 0.87%	29,006 $1.39 Million
Q3 2024 Nov 12, 2024	SELL	$51.3 - $64.42 $9,490 - $11,917	-185 Reduced 0.63%	29,261 $1.67 Million
Q2 2024 Aug 13, 2024	BUY	$37.81 - $52.4 $57,849 - $80,172	1,530 Added 5.48%	29,446 $1.54 Million
Q1 2024 May 10, 2024	BUY	$33.68 - $41.95 $51,867 - $64,603	1,540 Added 5.84%	27,916 $1.14 Million
Q4 2023 Jan 16, 2024	BUY	$33.32 - $42.1 $508,496 - $642,488	15,261 Added 137.3%	26,376 $974,000
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $811,781 - $980,327	-22,265 Reduced 66.7%	11,115 $424,000
Q2 2023 Jul 12, 2023	BUY	$30.28 - $38.74 $759,422 - $971,599	25,080 Added 302.17%	33,380 $1.2 Million
Q1 2023 May 02, 2023	SELL	$32.86 - $55.7 $578,861 - $981,211	-17,616 Reduced 67.97%	8,300 $316,000
Q4 2022 Feb 06, 2023	BUY	$40.06 - $59.44 $802,041 - $1.19 Million	20,021 Added 339.63%	25,916 $1.47 Million
Q3 2022 Oct 18, 2022	BUY	$38.53 - $51.78 $227,134 - $305,243	5,895 New	5,895 $233,000
Q1 2022 Apr 05, 2022	SELL	$31.97 - $41.06 $476,736 - $612,286	-14,912 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$31.82 - $40.75 $147,644 - $189,080	-4,640 Reduced 23.73%	14,912 $600,000
Q3 2021 Oct 15, 2021	BUY	$38.47 - $46.42 $218,047 - $263,108	5,668 Added 40.82%	19,552 $795,000
Q2 2021 Jul 21, 2021	SELL	$38.84 - $51.31 $72,203 - $95,385	-1,859 Reduced 11.81%	13,884 $630,000
Q1 2021 Apr 05, 2021	BUY	$39.51 - $51.45 $164,559 - $214,289	4,165 Added 35.97%	15,743 $656,000
Q4 2020 Jan 20, 2021	BUY	$25.81 - $43.62 $179,947 - $304,118	6,972 Added 151.37%	11,578 $494,000
Q3 2020 Oct 19, 2020	BUY	$25.74 - $29.63 $118,558 - $136,475	4,606 New	4,606 $121,000
Q4 2018 Feb 13, 2019	SELL	$13.33 - $18.66 $90,177 - $126,234	-6,765 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $112,840 - $124,543	6,765 New	6,765 $123,000
Q1 2018 May 14, 2018	SELL	$17.06 - $21.2 $36,252 - $45,050	-2,125 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $35,593 - $44,200	2,125	2,125 $43,000

Others Institutions Holding HALO

# of Institutions

536

Shares Held

123M

Call Options Held

294K

Put Options Held

169K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.95B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Halozyme Therapeutics, Inc. Transaction History